On October 2, Amgen declined 3.12% in regular trading, trading at $408.245 USD/share, with Turnover of $656 million.

Within the Biotechnology sector where Amgen belongs, the overall sector showed mixed performance. Among individual stocks, Moderna down 1.76%, United Therapeutics up 5.3%, AbbVie down 0.42%, Natera down 1.08%, Regeneron Pharmaceuticals down 2.91%.

(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)